Life Sciences Drug Pricing & Reimbursement Infusion Confusion in 2025 In this blog, we’re focused on understanding provider sensitivity to drug contracting mechanisms and how markups influence reimbursement.
Market Trends Studies show price transparency is demystifying the healthcare market From trauma centers to costs at large, we’re seeing things we’ve never seen before. Literally.
Life Sciences Pharmaceutical Price Transparency Legislative Brief A tale of two regulations and one pending Congressional approval
Life Sciences Trucks, Drugs, and Price Transparency Let's learn about drug net cost recovery by leveraging price transparency data and everybody’s favorite four-wheeler.
Payer Data Prescription Drugs are Coming to a Payer MRF Near You CMS announced the deferred enforcement period is coming to an end.
Price Transparency The Difference Between Claims Data & Price Transparency Data Like all good things, it’s ~nuanced~
Life Sciences Drug Prices Are About To Be Under the CMS Looking Glass 2024 Proposed Rule increases what drug reporting hospitals must include within their MRFs.
